Member Info for daveycaferacer

no more demergers, they need to get a decent Corporate Advisor. For the future they should probably focus on licensing deals with big Pharma.

Beigene listing

https://www.caixinglobal.com/2021-06-29/beigene-cleared-for-31-billion-star-market-ipo-101732999.html

tacly, amones, this is a useful guide although I hope a STAR market listing will be forthcoming soon.

https://www.hkex.com.hk/-/media/HKEX-Market/Mutual-Market/Stock-Connect/Getting-Started/Information-Booklet-and-FAQ/Information-Book-for-Investors/Investor_Book_En.pdf

Beigene are looking to do it shortly once they clear some hurdles.

Interesting that they have posted 2 separate notes today

One focused on the IPO and valuation and a further one focused more on the pipeline and prospects

https://www.trinitydelta.org/wp-content/uploads/2021/07/HUTCHMED-Update-IPO-210706.pdf
https://www.trinitydelta.org/wp-content/uploads/2021/07/HUTCHMED-Update-210706.pdf

I meant, secondary listings in London and New York.

thanks tacly and amones

The most interesting aspect for me in the last couple of weeks is that we are now a HK based/listed Company with secondary listings in London & HK. That is exactly what will give the Company a realistic valuation as we go forward and I am very happy with it. On the Capital markets front and in the clinic and on the regulatory side the last few weeks have been fantastic.

I've not seen much coverage in the HK media

https://talkmarkets.com/content/global-markets/week-in-review-beigene-plans-3-billion-ipo-on-shanghai-star-market?post=318660

https://www.cnbc.com/video/2021/06/30/hutchmed-eyes-drug-licensing-ma-opportunities-following-hk-listing.html

"Nasdaq listing is more beneficial for accustem as americans have deeper pockets and take more with investments."

Having livedf and worked in American I can say that is not true at all, you can't generalise. There are millions of daytraders using their stimulus cheques to trade fractional shares in Tesla and Dogecoin! They aren't investors but like the gamification aspect.

HK did like the news, spiked shortly after opening at £6.73 equivalent, currently trading at £6.08

NASDAQ as ignored this news but I expect HK to love it when it opens at 02:30 BST!!!

This is a fantastic achievement - from memory Christian said on a recent Investor event that there was over 800,000 pages in the submission so the level of detail and the amount of work is astounding. Average approval times for Fast Track is around 8 months so we could see Surufatinib launched by Q1 2021.

The progress the Company has made in the last few months is incredible.

hi Jatw - I look at a number of metrics, P/S, EV/S, P/E etc etc and will post more later. I have always had the view that the Company should have a higher valuation, more in line with Edison and Trinity Delta. With forecast revs of just over $1bn by 2025, and the start of significant cashflow generation by 2024 I hope people can see where this is heading.

I think the Company is right to adopt the Hong Kong Corporate Governance Code in replacement of the UK Corporate Governance Code. London is after all effectively a secondary listing. The HK listing and potential future STAR market listings is what will control the share price and Company valuation in the future.

For similar Co's I look at Beigene, Innovent and Genmab

Genmab EV/S = 34
Innovent EV/S = 31
Genmab EV/S = 15
HUTCHMED EV/S = 16

We are still way way way undervalued IMO

I've met and spoken to Mark Slater on numerous occasions over the years and being in his Fund is why I originally invested in the Company over a decade ago. It was still a 2.4% constituent holding in May, has that changed?

https://slaterinvestments.com/wp-content/uploads/2021/06/Slater-Growth-Fund-A-Fact-Sheet-May-21.pdf

Just in case anyone gets up in the morning and is worried, please beer the following in mind:-

When is the next Hong Kong Stock Exchange holiday?
The next Hong Kong Stock Exchange holiday is Special Administrative Region Establishment Day and will be observed on Thursday, July 1, 2021 which is tomorrow.

thx Goldstinger & jatw.... I've been waiting for the day when Hutcmhed would come home to HK and hoped it would be successful. I'm hoping/expecting a CNBC HK interview at some point in the next few days. There's so much material news still to come from the Company.

I will be disposing of my entire holding in 2028 @ around £32 per share

I a not selling until 2028 but there are no lives quotes on the London market at the moment suggesting the order book is probably very interesting for our MM friends!!

definitely alive, definitely prosper